表紙
市場調査レポート

新生児スクリーニング市場:検査別(乾血スポット、聴覚検査、CCHD)、技術別(タンデム質量分析、免疫測定、酵素アッセイ、電気泳動、パルスオキシメーター)、設備、アクセサリ、試薬およびアッセイキット:世界市場予測

NewBorn Screening Market by Test Type (Dried Blood Spot, Hearing Screening, CCHD), Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit - Global Forecast to 2019

発行 MarketsandMarkets 商品コード 307745
出版日 ページ情報 英文 242 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。
Back to Top
新生児スクリーニング市場:検査別(乾血スポット、聴覚検査、CCHD)、技術別(タンデム質量分析、免疫測定、酵素アッセイ、電気泳動、パルスオキシメーター)、設備、アクセサリ、試薬およびアッセイキット:世界市場予測 NewBorn Screening Market by Test Type (Dried Blood Spot, Hearing Screening, CCHD), Technology (Tandem Mass Spectrometry, Immunoassay, Enzyme Assay, Electrophoresis, Pulse Oximeter), Instrument, Accessories, Reagent & Assay Kit - Global Forecast to 2019
出版日: 2014年06月25日 ページ情報: 英文 242 Pages
概要

世界の新生児スクリーニング市場は2013年に4億3,890万米ドルになり、今後5年間はCAGR11.0%で拡大すると予測されています。これは法規制での義務化、技術的進歩、政府の支援などの恩恵によるところが多いものの、トレーニングを積んだ専門家の不足や社会経済的障壁などの要因が市場の成長を阻害するとみられています。

当レポートでは、新生児スクリーニング市場について調査し、種類別、技術別、製品別、および地域別の動向、参入企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 プレミアムインサイト

  • 技術動向
  • 成功の秘訣
  • ポーターズファイブフォース分析
  • 法規制環境
  • 償還シナリオ:新生児検査プログラム
  • 技術ライフサイクル
  • 戦略的ベンチマーキング

第4章 市場概要

  • イントロダクション
    • 新生児スクリーニングにおける一般的適応
  • 市場セグメンテーション
  • 市場動向
    • 促進因子
    • 阻害因子
    • 機会
    • 課題
  • 市場シェア分析

第5章 新生児スクリーニング市場:種類別

  • イントロダクション
  • 乾血スポット検査
  • 聴覚検査
  • 先天性心疾患(CCHD)検査

第6章 新生児スクリーニング市場:技術別

  • イントロダクション
  • タンデム質量分析
  • 電気泳動
  • 免疫測定と酵素アッセイ
  • DNAアッセイ
  • 聴覚検査技術
  • パルスオキシメータースクリーニング技術

第7章 新生児スクリーニング市場:製品別

  • イントロダクション
  • 設備
    • イントロダクション
    • 新生児疾患スクリーニング
    • 新生児聴覚検査装置
    • 聴覚検査装置
    • パルスオキシメーター
  • 試薬およびアッセイキット

第8章 新生児スクリーニング市場:地域別

  • イントロダクション
  • 北米
  • 南米
  • 欧州
  • アジア
  • その他

第9章 競合環境

  • イントロダクション
  • 提携、協定、連携、契約
  • 新製品上市
  • 拡大
  • 買収
  • 認可

第10章 企業プロファイル

  • AB Sciex LLC
  • Perkinelmer, Inc.
  • Waters Corporation
  • Covidien Plc
  • Masimo Corporation
  • GE Healthcare
  • Trivitron Healthcare
  • Agilent Technologies Inc.
  • Bio-Rad Laboratories, Inc.
  • Natus Medical Incorporated

図表

目次
Product Code: MD 2549

The global newborn screening market is categorized on the basis of test type, technology, product, and geography. The mass spectrometry market is expected to register the highest growth rate in the newborn screening market by technology, during the forecast period. This high growth is attributed to various nations opting for expanded newborn screening. Tandem mass spectrometry is a fundamental instrument used for expanded newborn screening. Furthermore, various conferences and symposiums are being conducted to spread awareness for the use of such technologies. For instance, in May 2013, the Joint Meeting of the Newborn Screening and Genetic Testing Symposium was organized in Atlanta. The symposium was aimed to discuss national and international newborn screening, genetic testing, and policy issues.

Major factors contributing to growth of newborn screening include government support in the form funding and rising awareness regarding new technologies. Furthermore, owing to continuous advancements in technology, new devices are being launched in the market which is another major factor providing impetus for growth of the market. The emerging Asian region and advent of next-generation sequencing technology are likely to provide opportunities for newborn screening market to grow. However, factors such as lack of trained professional infrastructure and socio-economical barriers may restrain the growth of this market.

The Asian region is expected to serve as a new revenue pocket for the newborn screening market in the coming five years.

Apart from the comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players in the last three years. In addition, the company profiles comprise the basic views on the key players in the newborn screening market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecasts of future trends will help the key players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report can use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios of top players in the human identification market. The report analyzes the newborn screening market by test type, technology, product, and geography
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the newborn screening market
  • Competitive Assessment: In-depth assessment of market strategies, geographic and business segments, and product portfolios of leading players in the newborn screening market
  • Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the market for various newborn screening products across geographies
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the newborn screening market

Table of Contents

1. Introduction

  • 1.1. Objectives of the Study
    • 1.1.1. Reasons to Buy the Report
  • 1.2. Scope of the Report
    • 1.2.1. Markets Covered
    • 1.2.2. Limitations of the Study
  • 1.3. Stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Market Size Estimation
    • 1.4.2. Market Crackdown & Data Triangulation
    • 1.4.3. Market Share Estimation
    • 1.4.4. Key Data Points From Primary Sources
    • 1.4.5. Key Data From Secondary Sources
    • 1.4.6. Assumptions

2. Executive Summary

3. Premium Insights

  • 3.1. Technology Trends
  • 3.2. Winning Imperative
    • 3.2.1. Investments in R&D Activities For Product Innovation
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Threats of New Entrants
    • 3.3.2. Bargaining Power of Suppliers
    • 3.3.3. Bargaining Power of Buyers
    • 3.3.4. Rivalry Amongst Existing Players
    • 3.3.5. Threat of Subsitutes
  • 3.4. Regulatory Environment
  • 3.5. Reimbursement Scenario: Newborn Testing Program
  • 3.6. Technology Life Cycle
  • 3.7. Strategic Benchmarking

4. Market Overview

  • 4.1. Intoduction
    • 4.1.1. Common Indications in Newborn Screening
      • 4.1.1.1. Phenylketonuria (PKU)
      • 4.1.1.2. Congenital Hypothyroidism (CH)
      • 4.1.1.3. Galactosemia
      • 4.1.1.4. Biotinidase Deficiency
      • 4.1.1.5. Congenital Adrenal Hyperplasia (CAH)
      • 4.1.1.6. Cystic Fibrosis (CF)
      • 4.1.1.7. Sickle Cell Disease
      • 4.1.1.8. Maple Syrup Urine Disease
      • 4.1.1.9. Tryosinemia
      • 4.1.1.10. Medium-Chain Acyl-Coa Dehydrogenase (MCAD) Deficiency
      • 4.1.1.11. Congenital Toxoplasmosis
      • 4.1.1.12. Newborn Hearing Loss
      • 4.1.1.13. Critical Congenital Heart Diseases
  • 4.2. Market Segmentation
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
      • 4.3.1.1. Benefits Related to Newborn Testing to Propel the Growth of the Market
      • 4.3.1.2. Legislations and Mandates Demands the Implementation of Newborn Screening Program
      • 4.3.1.3. Government Support, An Impetus For Newborn Screening Market
      • 4.3.1.4. Raising Awareness to Trigger the Growth of the Market
      • 4.3.1.5. Technological Innovations to Propel the Growth of the Market
      • 4.3.1.6. Expanding Panel of Newborn Diseases to Bolster the Growth of the Market
      • 4.3.1.7. Rising Incidences of Congenital Heart Defects(Chd)to Propel the CCHD Screening Market
    • 4.3.2. Restraints
      • 4.3.2.1. Lack of Professional Infrastructure May Hinder the Growth of the Market
      • 4.3.2.2. Socio-Economic Barriers Are Likely to Restrain the Growth of the Market
    • 4.3.3. Opportunities
      • 4.3.3.1. Asian Region Presents Significant Growth Opportunities
      • 4.3.3.2. Screening of Genetic Disorders
      • 4.3.3.3. Next Generation Sequencing(Ngs), An Upcoming Technology in the Newborn Screening Market
      • 4.3.3.4. Digital Microfluidics, A New Opportunity Area For Newborn Screening Market
    • 4.3.4. Challenges
      • 4.3.4.1. High Cost of Automation
      • 4.3.4.2. Survival of Small Players and New Entrants
      • 4.3.4.3. Lack of Uniformity of Newborn Testing Policies and Procedures Across the Globe
  • 4.4. Market Share Analysis

5. Newborn Screening Market, By Test Type

  • 5.1. Introduction
  • 5.2. Dry Blood Spot Test
  • 5.3. Hearing Screen Test
  • 5.4. Critical Congenital Heart Diseases (CCHD)Test

6. Newborn Screening Market, By Technology

  • 6.1. Introduction
  • 6.2. Tandem Mass Spectrometry (TMS)
  • 6.3. Electrophoresis
  • 6.4. Immunoassays and Enzymatic Assays
  • 6.5. Dna-Based Assays
  • 6.6. Hearing Screen Technology
  • 6.7. Pulse Oximetry Screening Technology

7. Newborn Screening Market, By Product Type

  • 7.1. Introduction
  • 7.2. Instruments
    • 7.2.1. Introduction
    • 7.2.2. Newborn Disorder Screening Instrument
    • 7.2.3. Newborn Hearing Screening Instruments
    • 7.2.4. Hearing Screening Devices
      • 7.2.4.1. Hearing Screening Accessories
    • 7.2.5. Pulse Oximeters
  • 7.3. Reagents and Assay Kits

8. Newborn Screening Market, By Geography

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. Need For Reducing Healthcare Costs, A Major Driver For the U.S. Newborn Screening Market
    • 8.2.2. Government Support, An Impetus For the Market
    • 8.2.3. Newborn Screening Program in Canada
    • 8.2.4. Newborn Hearing Screening Program in Canada
    • 8.2.5. Issues Over Privacy Rights of Families May Hinder the Growth of the Canadian Market
    • 8.2.6. Symposiums and Meetings to Trigger the Growth of the Newborn Screening Market
  • 8.3. South America
    • 8.3.1. Growth in the South American Market to Be Hinged At Brazil
    • 8.3.2. Researches to Enhance the Newborn Screening Program
    • 8.3.3. Lack of Trained Professionals to Hinder the Growth of the Newborn Hearing Screening Market
  • 8.4. Europe
    • 8.4.1. European Union Initiatives to Propel the Growth of the Market
    • 8.4.2. Newborn Screening Program in Various European Countries
    • 8.4.3. Conferences to Raise Awareness Regarding CCHD Screening
    • 8.4.4. Newborn Hearing Screening Program in Europe
    • 8.4.5. Government Initiatives to Bolster the Growth of the European Market
    • 8.4.6. Launch of New & Advanced Products to Propel the Growth of the European Market
    • 8.4.7. Conferences to Boost the Growth of the Newborn Screening Market
  • 8.5. Asia
    • 8.5.1. Government Initiatives to Drive the Growth of Asian Market
      • 8.5.1.1. Japanese Government Initiative
      • 8.5.1.2. Indian Government Initiatives
      • 8.5.1.3. Philippines Government Initiatives
    • 8.5.2. Collaboration Amongst Leading Players and Government to Boost the Chinese Market
  • 8.6. ROW
    • 8.6.1. Newborn Screening Program in Australia and New Zealand
    • 8.6.2. Newborn Screening Program in South Africa
    • 8.6.3. African & Middle East Countries Taking Initiatives to Launch and Improve their Newborn Tesing Program
    • 8.6.4. Support By Foreign Countries to Boost the ROW Market

9. Competitive Landscape

  • 9.1. Introduction
  • 9.2. Partnerships, Agreements, Collaborations & Contracts
  • 9.3. New Product Launches
  • 9.4. Expansions
  • 9.5. Acquisitions
  • 9.6. Approvals

10. Company Profiles

  • 10.1. AB Sciex LLC (A Subsidiary of Danaher Corporation)
    • 10.1.1. Business Overview
    • 10.1.2. Company Snapshot
    • 10.1.3. Product Porfolio
    • 10.1.4. Key Strategy
    • 10.1.5. Recent Developments
    • 10.1.6. SWOT Analysis
    • 10.1.7. MNM View
  • 10.2. Perkinelmer, Inc.
    • 10.2.1. Business Overview
    • 10.2.2. Company Snapshot
    • 10.2.3. Products & Services
    • 10.2.4. Key Strategy
    • 10.2.5. Recent Developments
    • 10.2.6. SWOT Analysis
    • 10.2.7. MNM View
  • 10.3. Waters Corporation
    • 10.3.1. Business Overview
    • 10.3.2. Company Snapshot
    • 10.3.3. Product Portfolio
    • 10.3.4. Key Strategy
    • 10.3.5. Recent Developments
    • 10.3.6. SWOT Analysis
    • 10.3.7. MNM View
  • 10.4. Covidien Plc
    • 10.4.1. Business Overview
    • 10.4.2. Company Snapshot
    • 10.4.3. Product Portfolio
    • 10.4.4. Key Strategy
    • 10.4.5. Recent Developments
  • 10.5. Masimo Corporation
    • 10.5.1. Business Overview
    • 10.5.2. Company Snapshot
    • 10.5.3. Product Portfolio
    • 10.5.4. Key Strategy
    • 10.5.5. Recent Developments
    • 10.5.6. SWOT Analysis
    • 10.5.7. MNM View
  • 10.6. GE Healthcare (Subsidiary of General Electric Company)
    • 10.6.1. Business Overview
    • 10.6.2. Company Snapshot
    • 10.6.3. Product Portfolio
    • 10.6.4. Key Strategy
    • 10.6.5. Recent Development
  • 10.7. Trivitron Healthcare
    • 10.7.1. Business Overview
    • 10.7.2. Financials
    • 10.7.3. Product Portfolio
    • 10.7.4. Key Strategy
    • 10.7.5. Recent Developments
  • 10.8. Agilent Technologies Inc.
    • 10.8.1. Business Overview
    • 10.8.2. Company Snapshot
    • 10.8.3. Product Portfolio
    • 10.8.4. Key Strategy
    • 10.8.5. Recent Developments
  • 10.9. Bio-Rad Laboratories, Inc.
    • 10.9.1. Business Overview
    • 10.9.2. Company Snapshot
    • 10.9.3. Product Portfolio
    • 10.9.4. Key Strategy
    • 10.9.5. Recent Developments
  • 10.10. Natus Medical Incorporated
    • 10.10.1. Business Overview
    • 10.10.2. Company Snapshot
    • 10.10.3. Product Portfolio
    • 10.10.4. Key Strategy
    • 10.10.5. Recent Developments
    • 10.10.6. SWOT Analysis
    • 10.10.7. MNM View

List of Tables

  • Table 1: Scope
  • Table 2: Global Newborn Screening Market Size, By Technology, 2012-2019 ($Million)
  • Table 3: Market Segmentation
  • Table 4: Global Market Size, By Test Type, 2012-2019 ($Million)
  • Table 5: Newborn Screening Test Type Market Size, By Geography, 2012-2019 ($Million)
  • Table 6: Dry Blood Spot Test Market Size, By Geography, 2012-2019 ($Million)
  • Table 7: Hearing Screen Test Market Size, By Geography, 2012-2019 ($Million)
  • Table 8: Critical Congenital Heart Diseases (CCHD) Test Market Size, By Geography, 2012-2019 ($Million)
  • Table 9: Global Newborn Screening Market Size, By Technology, 2012-2019 ($Million)
  • Table 10: Newborn Screening Technology Market Size, By Geography, 2012-2019 ($Million)
  • Table 11: Tandem Mass Spectrometry Market Size, By Geography, 2012-2019 ($Million)
  • Table 12: Electrophoresis Market Size, By Geography, 2012-2019 ($Million)
  • Table 13: Immunoassay and Enzymatic Assays Market Size, By Geography, 2012-2019 ($Million)
  • Table 14: Dna-Based Assay Market Size, By Geography, 2012-2019 ($Million)
  • Table 15: Hearing Screen Technology Market Size, By Geography, 2012-2019 ($Million)
  • Table 16: Pulse Oximetry Screening Technology Market Size, By Geography, 2012-2019 ($Million)
  • Table 17: Global Newborn Screening Market Size, By Product Type, 2012-2019 ($Million)
  • Table 18: Newborn Screening Products Market Size, By Geography, 2012-2019 ($Million)
  • Table 19: Newborn Screening Instruments Market Size, By Geography, 2012-2019 ($Million)
  • Table 20: Newborn Screening Instruments Market Size, By Geography, 2012-2019 ($Million)
  • Table 21: Newborn Disorder Screening Instruments Market Size, By Geography, 2012-2019 ($Million)
  • Table 22: Newborn Hearing Screening Instruments Market Size, By Product Type, 2014-2019 ($Million)
  • Table 23: Newborn Hearing Screening Instruments Market Size, By Geography, 2014-2019 ($Million)
  • Table 24: Hearing Screening Device Market Size, By Geography, 2012-2019 ($Million)
  • Table 25: Hearing Screening Accessories Market Size, By Geography, 2012-2019 ($Million)
  • Table 26: Newborn Pulse Oximeters Market Size, By Geography, 2012-2019 ($Million)
  • Table 27: Reagents and Assay Kits Market Size, By Geography, 2012-2019 ($Million)
  • Table 28: Global Newborn Screening Market Size, By Geography, 2012-2019 ($Million)
  • Table 29: U.S.: Newborn Disorder Screening Status
  • Table 30: U.S.: Critical Congenital Heart Disease (CCHD) Screening Implementation
  • Table 31: Canada: Newborn Disorder Screening Status
  • Table 32: North America: Newborn Screening Market Size, By Technology, 2012-2019 ($Million)
  • Table 33: North America: Market Size, By Test Type, 2012-2019 ($Million)
  • Table 34: North America: Market Size, By Product Type, 2012-2019 ($Million)
  • Table 35: North America: Newborn Screening Instruments Market Size, By Type, 2012-2019 ($Million)
  • Table 36: North America: Newborn Hearing Screening Instruments Market Size, By Product Type, 2012-2019 ($Million)
  • Table 37: South America: Market Size, By Technology, 2012-2019 ($Million)
  • Table 38: South America: Market Size, By Test Type, 2012-2019 ($Million)
  • Table 39: South America: Market Size, By Product Type, 2012-2019 ($Million)
  • Table 40: South America: Newborn Screening Instruments Market Size, By Type, 2012-2019 ($Million)
  • Table 41: South America: Newborn Hearing Screening Instruments Market Size, By Product Type, 2012-2019 ($Million)
  • Table 42: Europe: Newborn Screening Market Size, By Technology, 2012-2019 ($Million)
  • Table 43: Europe: Market Size, By Test Type, 2012-2019 ($Million)
  • Table 44: Europe: Market Size, By Product Type, 2012-2019 ($Million)
  • Table 45: Europe: Newborn Screening Instruments Market Size, By Type, 2013-2019 ($Million)
  • Table 46: Europe: Newborn Hearing Screening Instruments Market Size, By Product Type, 2012-2019 ($Million)
  • Table 48: Asia: Newborn Screening Market Size, By Technology, 2012-2019 ($Million)
  • Table 49: Asia: Market Size, By Test Type, 2012-2019 ($Million)
  • Table 50: Asia: Market Size, By Product Type, 2012-2019 ($Million)
  • Table 51: Asia: Newborn Screening Instruments Market Size, By Type, 2012-2019 ($Million)
  • Table 52: Asia: Newborn Hearing Screening Instruments Market Size, By Product Type, 2012-2019 ($Million)
  • Table 53: Newborn Hearing Screening Program
  • Table 54: ROW: Newborn Screening Market Size, By Technolgy, 2012-2019 ($Million)
  • Table 55: ROW: Market Size, By Test Type, 2012-2019 ($Million)
  • Table 56: ROW: Market Size, By Product Type, 2012-2019 ($Million)
  • Table 57: ROW: Newborn Screening Instruments Market Size, By Type, 2012-2019 ($Million)
  • Table 58: ROW: Newborn Hearing Screening Instruments Market Size, By Product Type, 2012-2019 ($Million)
  • Table 59: Partnerships, Agreements, Collaborations and Contracts
  • Table 60: New Product Launches
  • Table 61: Expansions
  • Table 62: Acquisitions
  • Table 63: Approvals

List of Figures

  • Figure 1: Forecast Model
  • Figure 2: Market Size Estimation Methodology
  • Figure 3: Data Triangulation
  • Figure 4: Porter's Five Forces Analysis
  • Figure 5: Technology Life Cycle
  • Figure 6: Dried Blood Spot Test Instrument Manufacturers: Strategy
  • Figure 7: Market Share Analysis, By Key Players, 2013
  • Figure 8: New Born Screening By Test Type
  • Figure 9: Global Market Size, By Test Type, 2012-2019 ($Million)
  • Figure 10: New Born Screening Market By Technology
  • Figure 11: Newborn Screening : Tapped & Untapped Market
  • Figure 12: High Growth Potential Market
  • Figure 13: Key Growth Strategies, Newborn Screening Market, 2011-2014
Back to Top